Role of Combined Embolization and Ablation in Management of Renal Masses

Abstract

Combination of minimally invasive treatment modalities is being increasingly utilized to improve local tumor control and overall survival. In the liver, the combination of embolization and ablation results in equivalent overall survival and intrahepatic disease progression as surgical resection for lesions smaller than 7 cm. Ablation alone for small renal masses up to 4 cm results in excellent local tumor control and lack of residual enhancement to suggest viable tumor. A small number of studies have been performed combining embolization and ablation, which result in high rates of local tumor control for tumors smaller than 5 cm. Based on this small cohort, combined embolization and ablation may be most indicated for central or mixed tumors where ablation alone suffers from the greatest degree of “heat sink” effect. This article reviews the theory, methods, and outcomes of combining percutaneous ablative and embolic modalities in the treatment of renal masses.

Keywords

renal cancer - kidney cancer - embolization - ablation - combination therapy - interventional radiology

• References

• 1 Ahrar K, Matin S, Wood CG , et al. Percutaneous radiofrequency ablation of renal tumors: technique, complications, and outcomes. J Vasc Interv Radiol 2005; 16 (5) 679-688
• 2 Clark TWI, Malkowicz B, Stavropoulos SW , et al. Radiofrequency ablation of small renal cell carcinomas using multitined expandable electrodes: preliminary experience. J Vasc Interv Radiol 2006; 17 (3) 513-519
• 3 Gervais DA, McGovern FJ, Arellano RS, McDougal WS, Mueller PR. Radiofrequency ablation of renal cell carcinoma: part 1, Indications, results, and role in patient management over a 6-year period and ablation of 100 tumors. AJR Am J Roentgenol 2005; 185 (1) 64-71
• 4 Gervais DA, McGovern FJ, Wood BJ, Goldberg SN, McDougal WS, Mueller PR. Radio-frequency ablation of renal cell carcinoma: early clinical experience. Radiology 2000; 217 (3) 665-672
• 5 Zagoria RJ, Traver MA, Werle DM, Perini M, Hayasaka S, Clark PE. Oncologic efficacy of CT-guided percutaneous radiofrequency ablation of renal cell carcinomas. AJR Am J Roentgenol 2007; 189 (2) 429-436
• 6 Elnekave E, Erinjeri JP, Brown KT , et al. Long-term outcomes comparing surgery to embolization-ablation for treatment of solitary HCC<7 cm. Ann Surg Oncol 2013; 20 (9) 2881-2886
• 7 Nurmi M, Satokari K, Puntala P. Renal artery embolization in the palliative treatment of renal adenocarcinoma. Scand J Urol Nephrol 1987; 21 (2) 93-96
• 8 Roach H, Whittlestone T, Callaway MP. Life-threatening hematuria requiring transcatheter embolization following radiofrequency ablation of renal cell carcinoma. Cardiovasc Intervent Radiol 2006; 29 (4) 672-674
• 9 Schwartz MJ, Smith EB, Trost DW, Vaughan Jr ED. Renal artery embolization: clinical indications and experience from over 100 cases. BJU Int 2007; 99 (4) 881-886
• 10 Zielinski H, Szmigielski S, Petrovich Z. Comparison of preoperative embolization followed by radical nephrectomy with radical nephrectomy alone for renal cell carcinoma. Am J Clin Oncol 2000; 23 (1) 6-12
• 11 Gervais DA, McGovern FJ, Arellano RS, McDougal WS, Mueller PR. Renal cell carcinoma: clinical experience and technical success with radio-frequency ablation of 42 tumors. Radiology 2003; 226 (2) 417-424
• 12 Atwell TD, Schmit GD, Boorjian SA , et al. Percutaneous ablation of renal masses measuring 3.0 cm and smaller: comparative local control and complications after radiofrequency ablation and cryoablation. AJR Am J Roentgenol 2013; 200 (2) 461-466
• 13 Alasker A, Williams SK, Ghavamian R. Small renal mass: to treat or not to treat. Curr Urol Rep 2013; 14 (1) 13-18
• 14 Bakke A, Göthlin JH, Haukaas SA, Kalland T. Augmentation of natural killer cell activity after arterial embolization of renal carcinomas. Cancer Res 1982; 42 (9) 3880-3883
• 15 Nakano H, Nihira H, Toge T. Treatment of renal cancer patients by transcatheter embolization and its effects on lymphocyte proliferative responses. J Urol 1983; 130 (1) 24-27
• 16 Tanaka T, Isfort P, Braunschweig T , et al. Superselective particle embolization enhances efficacy of radiofrequency ablation: effects of particle size and sequence of action. Cardiovasc Intervent Radiol 2013; 36 (3) 773-782
• 17 Goldberg SN, Gazelle GS. Radiofrequency tissue ablation: physical principles and techniques for increasing coagulation necrosis. Hepatogastroenterology 2001; 48 (38) 359-367
• 18 Goldberg SN, Hahn PF, Tanabe KK , et al. Percutaneous radiofrequency tissue ablation: does perfusion-mediated tissue cooling limit coagulation necrosis?. J Vasc Interv Radiol 1998; 9 (1 Pt 1) 101-111
• 19 Arima K, Yamakado K, Kinbara H, Nakatsuka A, Takeda K, Sugimura Y. Percutaneous radiofrequency ablation with transarterial embolization is useful for treatment of stage 1 renal cell carcinoma with surgical risk: results at 2-year mean follow up. Int J Urol 2007; 14 (7) 585-590 , discussion 590
• 20 Nakasone Y, Kawanaka K, Ikeda O, Tamura Y, Yamashita Y. Sequential combination treatment (arterial embolization and percutaneous radiofrequency ablation) of inoperable renal cell carcinoma: single-center pilot study. Acta Radiol 2012; 53 (4) 410-414
• 21 Yamakado K, Nakatsuka A, Kobayashi S , et al. Radiofrequency ablation combined with renal arterial embolization for the treatment of unresectable renal cell carcinoma larger than 3.5 cm: initial experience. Cardiovasc Intervent Radiol 2006; 29 (3) 389-394
• 22 Uzzo RG, Novick AC. Nephron sparing surgery for renal tumors: indications, techniques and outcomes. J Urol 2001; 166 (1) 6-18